Advanced
  Home Compare Reports

Comparison with Similar Reports

Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hosp...

by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Home Care, ACC, Emergency Medical Services) Covid-19 Impact - Global Forecast to 2025

Publisher:        MarketsandMarkets

# of Pages:        244

Rating: 

1 User License $4,950

Publication Date:  October, 2020

Price:       $4,950 / User License





TABLE OF CONTENTS

 

 

1.... Introduction. 30

1.1            Objectives of the study. 30

1.2            market Definition. 31

1.2.1               Inclusions & Exclusions. 31

1.3            Market scope. 31

1.3.1               markets covered.. 31

1.3.2               YEARs considered for the study. 32

1.4            Currency. 32

1.5            Limitations. 33

1.6            stakeholders. 33

1.7            summary of changes. 33

2.... Research Methodology. 35

2.1            research Approach. 35

2.1.1               Research design.. 35

2.1.2               SECONDARY research.. 36

2.1.2.1             Key data from secondary sources. 37

2.1.3               Primary Research.. 37

2.1.4               Primary Sources. 37

2.1.4.1             Key data from primary sources. 38

2.1.4.2             Breakdown of Primaries. 39

FIGURE 1       Breakdown of Primary Interviews: By Company Type, Designation, and Region.. 39

2.2            market size estimation. 39

FIGURE 2       MARKET SIZE ESTIMATION: revenue share analysis (2019) 40

FIGURE 3       MARKET SIZE ESTIMATION: revenue share analysis (2019) 40

FIGURE 4       SUPPLY SIDE ANALYSIS: ventilators Market (2019) 41

2.3            data triangulation Approach. 44

FIGURE 5       data triangulation methodology. 44

2.4            Market share estimation. 45

2.5            assumptions for the study. 45

2.6            covid-19 health assessment. 46

2.7            covid-19 economic assessment. 46

2.8            assessment of the impact of covid-19 on the economic scenario. 47

FIGURE 6       criteria impacting the global economY. 47

FIGURE 7       scenarios of recovery from covid-19 in the global economy. 48

2.9            assessment of the impact of covid-19 on the economic scenario pertaining to the ventilators market. 49

3.... Executive Summary. 50

FIGURE 8       ventilators market, by mobility, 2020 vs. 2025 (USD Million) 50

FIGURE 9       ventilators market, by Type, 2020 vs. 2025 (USD Million) 51

FIGURE 10     ventilators market, by Interface, 2020 vs. 2025 (USD Million) 51

FIGURE 11     ventilators market, by Mode, 2020 vs. 2025 (USD Million) 52

FIGURE 12     ventilators market, by end user, 2020 vs. 2025 (USD Million) 53

FIGURE 13     Geographical snapshot of the ventilators market. 54

4.... Premium insights. 55

4.1            Ventilators Market overview.. 55

FIGURE 14     rising covid-19 patient population and growth in the prevalence of chronic respiratory diseases are factors driving the growth of the ventilators market. 55

4.2            regional Mix: Ventilators Market. 56

FIGURE 15     Apac to register A CAGR OF -28.3% during the forecast period (2020-2025) 56

4.3            VENTILATORS Market: Developing vs. Developed Countries. 56

FIGURE 16     Developing Markets to Register Higher Growth during the Forecast Period.. 56

5.... Market Overview.. 57

5.1            iNTRODUCTION. 57

5.2            mARKET DYNAMICS. 57

FIGURE 17     Ventilators Market: Drivers, Restraints, Opportunities,

and Challenges. 57

5.2.1               Drivers. 58

5.2.1.1             Rising prevalence of respiratory diseases. 58

TABLE 1         prevalence of COPD and Asthma in 2010 and 2016. 58

5.2.1.1.1             Urbanization and growing pollution levels. 58

FIGURE 18     DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION,

BY DISEASE (~every year) 59

FIGURE 19     urban population 2016 VS. 2019. 59

5.2.1.1.2             High prevalence of tobacco smoking. 60

FIGURE 20     Prevalence OF TOBACCO SMOKING AMONG ADULTS, by country, 2018. 60

5.2.1.1.3             Changing lifestyles. 60

FIGURE 21     Overweight Adult population statistics, by Country,

2010 vs. 2016 (% of total adult population) 61

5.2.1.2             Rapid growth in the geriatric population. 61

FIGURE 22     Geriatric Population, By Country, 2010 Vs. 2019. 61

5.2.1.3             Increasing number of preterm births. 62

FIGURE 23     NUmber of Preterm Births (Developed, Latin AmericaN, and Caribbean countries), 1990–2025. 62

5.2.1.4             Increasing number of intensive care units. 62

5.2.1.5             The outbreak of the COVID-19 pandemic. 63

5.2.2               restraints. 63

5.2.2.1             Dearth of skilled medical workers. 63

5.2.2.2             Reimbursement concerns. 63

5.2.2.3             Complications associated with the use of ventilators. 64

5.2.2.4             Reluctance among physicians for the adoption of new technologies. 64

5.2.3               Opportunities. 64

5.2.3.1             Growing demand for homecare therapeutic devices. 64

5.2.3.2             Technological advancements. 65

5.2.3.3             Growth opportunities in emerging countries. 65

5.2.4               challenges. 66

5.2.4.1             Lack of awareness and a large population of undiagnosed & undertreated patients. 66

5.2.4.2             Harmful effects of certain devices on neonates. 66

5.3            COVID-19 IMPACT ON THE ventilators market. 66

FIGURE 24     Impact of COVID-19 on the VENTILATORS MARKET. 67

5.4            Value chain analysis. 67

FIGURE 25     Value chain: ventilators market. 68

5.5            macroeconomic indicators (covid-19 focused) 69

6.... Industry Insights. 70

6.1            introduction. 70

6.2            Industry trends. 70

TABLE 2         market consolidation and the rising demand for portable ventilators are the major trends in the market. 70

6.2.1               rISING dEMAND FOR enhanced portable and compact ventilators. 71

6.2.2               Consolidation of the market. 71

FIGURE 26     Recent Acquisitions in the market. 71

6.2.3               Growing demand for multimodal ventilators. 72

6.2.4               Increasing adoption of non-invasive ventilation.. 72

6.2.5               non-medical companies entering the market to combat with the increasing demand of ventilators. 72

6.3            Artificial intelligence in the ventilators market. 73

6.3.1               Introduction.. 73

6.3.2               The Future of Healthcare—Big Data and Artificial Intelligence. 73

6.3.3               Knowledge-based Systems for Ventilation Management. 74

6.3.4               COVID-19 to Drive the Demand for Artificial Intelligence in ventilators. 75

6.4            Sensor Technologies in ventilators. 76

6.4.1               Introduction.. 76

6.4.2               Flow Sensors. 76

6.4.3               Oxygen Sensors. 76

6.4.4               Pressure sensors. 77



 

6.5            Technologies with high-growth potential. 77

6.5.1               E-Nose Technology. 77

6.5.2               MEMS technology. 78

6.5.3               ELECTROCHEMICAL technology. 78

6.5.4               ParaMagnetic technology. 78

6.5.5               wireless gas sensor technology. 78

6.6            REGULATORY analysis. 79

6.6.1               north america. 79

6.6.1.1             US. 79

FIGURE 27     classifications of medical devices by the US FDA. 79

6.6.1.2             Canada. 80

6.6.2               europe. 80

6.6.3               asia pacific. 80

6.6.3.1             Japan. 80

6.6.3.2             China. 81

6.6.3.3             India. 82

6.7            Factor Analysis. 82

6.7.1               Population ScenaRio.. 82

FIGURE 28     Total Population, By Country/Region.. 82

FIGURE 29     Urban Population, By country/region.. 83

FIGURE 30     Geriatric Population (AgeD above 65 Years) 83

6.7.2               Healthcare Expenditure. 84

FIGURE 31     THE us accounted for the highest Healthcare Expenditure

(% of GDP) 84

6.7.3               Target population.. 85

FIGURE 32     Target population for THE ventilators market. 85

FIGURE 33     covid-19 population, total population Vs. recovered population.. 85

7.... ventilators market, By mobility. 86

7.1            introduction. 87

FIGURE 34     Intensive care ventilators segment to continue to dominate the Ventilators market during the forecast period.. 87

TABLE 3         ventilators MARKET, BY Mobility, 2018-2025 (USD MILLION) 87

TABLE 4         ventilators MARKET, BY country, 2018-2025 (USD MILLION) 88

7.2            Intensive care ventilators. 88

TABLE 5         Major Products: ICU Ventilators. 89

TABLE 6         Intensive Care ventilators MARKET, BY type, 2018-2025 (USD MILLION) 90

TABLE 7         Intensive care ventilators market size, by country, 2018-2025 (USD Million) 91

TABLE 8         Intensive Care Ventilators Market, By Region, 2018-2025 (UNITS) 91

7.2.1               High-end ICU Ventilators. 92

7.2.1.1             Improving healthcare infrastructure and rising healthcare expenditure in developing countries to drive market growth. 92

TABLE 9         high-end ICU ventilators market, by country, 2018-2025 (USD Million) 92

TABLE 10       High-End ICU Ventilators Market, By Region, 2018-2025 (UNITS) 93

7.2.2               mid-end ICU Ventilators. 93

7.2.2.1             Mid-end ICU ventilators are in high demand owing to the

COVID-19 pandemic. 93

TABLE 11       mid-end ICU ventilators market, by country,

2018-2025 (USD Million) 94

TABLE 12       Mid-End ICU Ventilators Market, By Region, 2018-2025 (UNITS) 94

7.2.3               Basic ICU Ventilators. 95

7.2.3.1             Basic ICU ventilators are equipped with minimal features as compared to high-end and mid-end ICU ventilators. 95

TABLE 13       basic ICU ventilators market, by country, 2018-2025 (USD Million) 95

TABLE 14       Basic-End ICU Ventilators Market, By Region, 2018-2025 (UNITS) 96

7.3            portable/transportable Ventilators. 96

TABLE 15       Major Products: Portable/Transportable ventilators. 97

TABLE 16       portable/transportable Ventilators Market, by country,

2018-2025 (USD Million) 98

TABLE 17       portable/transportable Ventilators Market, By Region,

2018-2025 (UNITS) 99

8.... ventilators Market, By interface. 100

8.1            introduction. 101

FIGURE 35     Invasive ventilation segment accounted for the largest share of the Ventilators market in 2019. 101

TABLE 18       Ventilators Market, by Interface, 2018–2025 (USD Million) 101

8.2            Invasive VENTILATION. 102

8.2.1               Increasing cases of severity in COVID-19 patients and the rising prevalence of respiratory diseases to support market growth.. 102

TABLE 19       Major products: invasive ventilation.. 102

TABLE 20       Invasive ventilation market, by countrY, 2018–2025 (USD Million) 104

8.3            Non-invasive ventilation. 104

8.3.1               With the use of non-invasive ventilators, many complications associated with the treatment of respiratory, cardiovascular, and neurological diseases can be avoided   104

TABLE 21       Major products: Non-invasive ventilation.. 105

TABLE 22       non-invasive ventilation market, by country,

2018–2025 (USD Million) 106

9.... ventilators Market, By type. 107

9.1            introduction. 108

FIGURE 36     Adult/pediatric ventilators segment will continue to dominate the Ventilators market in the forecast period.. 108

TABLE 23       ventilators Market, by type, 2018–2025 (USD Million) 108



 

9.2            Adult/Pediatric Ventilators. 109

9.2.1               The increasing number of COVID-19 cases among adults has triggered the demand for adult ventilators. 109

TABLE 24       adult ventilators Market, by country, 2018–2025 (USD Million) 110

9.3            Infant/Neonatal Ventilators. 110

9.3.1               New technologies and innovations in the field of neonatal ventilators drives market growth.. 110

TABLE 25       infant/neonatal ventilators Market, by country,

2018–2025 (USD Million) 111

10.. ventilators market, By mode. 112

10.1          introduction. 113

FIGURE 37     Combined-mode ventilation segment will continue to dominate the Ventilators market during the forecast period.. 113

TABLE 26       Ventilators MARKET, BY Mode, 2018–2025 (USD Million) 113

10.2          Combined-mode ventilation. 114

10.2.1             combined-mode ventilation offers hybrid modes combining the features of volume-targeted and pressure-targeted ventilation.. 114

TABLE 27       combined-mode ventilation MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 114

10.3          Volume-mode Ventilation. 115

10.3.1             Assist-control ventilation (ACV) and synchronized intermittent-mandatory ventilation (SIMV) are the two types of volume-mode ventilation.. 115

TABLE 28       volume-mode VENTILATion MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 115

10.4          Pressure-mode ventilation. 116

10.4.1             protection against barotrauma and improved patient comfort drives market growth   116

TABLE 29       pressure-mode ventilation MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 116

10.5          Other modes. 117

TABLE 30       other ventilation modes MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 118

11.. ventilators Market, By end user. 119

11.1          introduction. 120

FIGURE 38     tHE HOSPITALS AND clinics segment continue to dominate the Ventilators market DURING THE FORECAST PERIOD.. 120

TABLE 31       Ventilators Market, by end user, 2018–2025 (USD Million) 120

11.2          Hospitals AND clinics. 121

11.2.1             The increasing patient volume due to COVID-19 is driving the growth of this segment  121

TABLE 32       ventilators Market for hospitals and clinics, by countrY,

2018–2025 (USD Million) 122

11.3          Home care. 122

11.3.1             Home care ventilators are convenient and can be used in the comfort of the patient’s home; key factor driving market growth.. 122

TABLE 33       ventilators Market for home care, by country, 2018–2025 (USD Million) 123

11.4          Ambulatory care centers. 124

11.4.1             Growing awareness and the importance of early diagnosis & treatment of chronic diseases has contributed to the growth of this segment. 124

TABLE 34       ventilators Market for ambulatory care centers, by country, 2018–2025 (USD Million) 125

11.5          Emergency Medical Services. 125

11.5.1             The high incidence of trauma injuries drives segment growth.. 125

TABLE 35       ventilators Market for emergency medical services, by country, 2018–2025 (USD Million) 126

12.. ventilators MARKET, BY region. 127

12.1          introduction. 128

TABLE 36       ventilators MARKET, BY region, 2018-2025 (USD MILLION) 128

12.2          NORTH AMERICA. 128

FIGURE 39     North aMerica: Ventilators market snapshot. 129

TABLE 37       north america: ventilators MARKET, BY country,

2018–2025 (USD MILLION) 130

TABLE 38       NORTH AMERICA: ventilators market, By mobility,

2018–2025 (USD MILLION) 130

TABLE 39       NORTH AMERICA: Intensive care ventilators market, By Type,

 2018–2025 (USD MILLION) 130

TABLE 40       NORTH AMERICA: ventilators market, By type,

2018–2025 (USD MILLION) 131

TABLE 41       NORTH AMERICA: ventilators market, By interface,

2018–2025 (USD MILLION) 131

TABLE 42       NORTH AMERICA: ventilators market, By Mode,

2018–2025 (USD MILLION) 131

TABLE 43       NORTH AMERICA: ventilators market, By end user,

2018–2025 (USD MILLION) 132

12.2.1             US. 132

12.2.1.1           US dominates the North American ventilator market due to the high burden of asthma & COPD in the country. 132

TABLE 44       US: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 133

TABLE 45       US: ventilators market, By mobility, 2018–2025 (USD MILLION) 133

TABLE 46       US: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 134

TABLE 47       US: ventilators market, By type, 2018–2025 (USD MILLION) 134

TABLE 48       US: ventilators market, By interface, 2018–2025 (USD MILLION) 134

TABLE 49       US: ventilators market, By Mode, 2018–2025 (USD MILLION) 135

TABLE 50       US: ventilators market, By end user, 2018–2025 (USD MILLION) 135

12.2.2             canada. 135

12.2.2.1           Increasing incidence of COPD is driving the adoption of ventilators in Canada. 135

FIGURE 40     Canada: asthma PREVALENCE, by age group, 2017 vs. 2018. 136

TABLE 51       CANADA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 136

TABLE 52       CANADA: ventilators market, By mobility, 2018–2025 (USD MILLION) 137

TABLE 53       CANADA: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 137

TABLE 54       CANADA: ventilators market, By type, 2018–2025 (USD MILLION) 137

TABLE 55       CANADA: ventilators market, By interface, 2018–2025 (USD MILLION) 138

TABLE 56       CANADA: ventilators market, By Mode, 2018–2025 (USD MILLION) 138

TABLE 57       CANADA: ventilators market, By end user, 2018–2025 (USD MILLION) 138

12.3          Europe. 139

FIGURE 41     Europe: Ventilators market snapshot. 140

TABLE 58       Europe: ventilators MARKET, BY country, 2018–2025 (USD MILLION) 141

TABLE 59       EUROPE: ventilators market, By mobility, 2018–2025 (USD MILLION) 141

TABLE 60       EUROPE: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 141

TABLE 61       EUROPE: ventilators market, By type, 2018–2025 (USD MILLION) 142

TABLE 62       EUROPE: ventilators market, By interface, 2018–2025 (USD MILLION) 142

TABLE 63       EUROPE: ventilators market, By Mode, 2018–2025 (USD MILLION) 142

TABLE 64       EUROPE: ventilators market, By end user, 2018–2025 (USD MILLION) 143

12.3.1             germany. 143

12.3.1.1           Germany dominated the ventilators market in Europe in 2019. 143

TABLE 65       GERMANY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 144

TABLE 66       GERMANY: ventilators market, By mobility, 2018–2025 (USD MILLION) 144

TABLE 67       GERMANY: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 144

TABLE 68       GERMANY: ventilators market, By type, 2018–2025 (USD MILLION) 145

TABLE 69       GERMANY: ventilators market, By interface,

2018–2025 (USD MILLION) 145

TABLE 70       GERMANY: ventilators market, By Mode, 2018–2025 (USD MILLION) 145

TABLE 71       GERMANY: ventilators market, By end user,

2018–2025 (USD MILLION) 146

12.3.2             france. 146

12.3.2.1           The highly advanced and well-established healthcare system in France drives market growth for ventilators. 146

TABLE 72       FRANCE: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 147

TABLE 73       FRANCE: ventilators market, By mobility, 2018–2025 (USD MILLION) 147

TABLE 74       FRANCE: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 147

TABLE 75       FRANCE: ventilators market, By type, 2018–2025 (USD MILLION) 148

TABLE 76       FRANCE: ventilators market, By interface, 2018–2025 (USD MILLION) 148

TABLE 77       FRANCE: ventilators market, By Mode, 2018–2025 (USD MILLION) 148

TABLE 78       FRANCE: ventilators market, By end user, 2018–2025 (USD MILLION) 149

12.3.3             UK. 149

12.3.3.1           Increasing healthcare expenditure is driving the growth of the ventilators market in the country  149

TABLE 79       UK: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 150

TABLE 80       UK: ventilators market, By mobility, 2018–2025 (USD MILLION) 150

TABLE 81       UK: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 150

TABLE 82       UK: ventilators market, By type, 2018–2025 (USD MILLION) 151

TABLE 83       UK: ventilators market, By interface, 2018–2025 (USD MILLION) 151

TABLE 84       UK: ventilators market, By Mode, 2018–2025 (USD MILLION) 151

TABLE 85       UK: ventilators market, By end user, 2018–2025 (USD MILLION) 152

12.3.4             ITALY. 152

12.3.4.1           Presence of a well-developed healthcare system in the country and rapid growth in the aging population to drive market growth. 152

TABLE 86       ITALY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 153

TABLE 87       ITALY: ventilators market, By mobility, 2018–2025 (USD MILLION) 153

TABLE 88       ITALY: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 153

TABLE 89       ITALY: ventilators market, By type, 2018–2025 (USD MILLION) 154

TABLE 90       ITALY: ventilators market, By interface, 2018–2025 (USD MILLION) 154

TABLE 91       ITALY: ventilators market, By Mode, 2018–2025 (USD MILLION) 154

TABLE 92       ITALY: ventilators market, By end user, 2018–2025 (USD MILLION) 155

12.3.5             spain.. 155

12.3.5.1           Ageing population and the increasing demand for home care services are the key factors driving market growth in Spain. 155

TABLE 93       SPAIN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 156

TABLE 94       SPAIN: ventilators market, By mobility, 2018–2025 (USD MILLION) 156

TABLE 95       SPAIN: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 156

TABLE 96       SPAIN: ventilators market, By type, 2018–2025 (USD MILLION) 157

TABLE 97       SPAIN: ventilators market, By interface, 2018–2025 (USD MILLION) 157

TABLE 98       SPAIN: ventilators market, By Mode, 2018–2025 (USD MILLION) 157

TABLE 99       SPAIN: ventilators market, By end user, 2018–2025 (USD MILLION) 158

12.3.6             netherlands. 158

12.3.6.1           Increasing patient population to support the market growth of ventilators in the Netherlands  158

TABLE 100     netherlands: KEY MACROINDICATORS FOR THE VENTILATORS MARKET. 158

TABLE 101     netherlands: ventilators market, By mobility,

2018–2025 (USD MILLION) 159

TABLE 102     netherlands: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 159

TABLE 103     netherlands: ventilators market, By type, 2018–2025 (USD MILLION) 159

TABLE 104     netherlands: ventilators market, By interface,

2018–2025 (USD MILLION) 160

TABLE 105     netherlands: ventilators market, By Mode,

2018–2025 (USD MILLION) 160

TABLE 106     netherlands: ventilators market, By end user,

2018–2025 (USD MILLION) 160

12.3.7             rest of europe. 161

TABLE 107     ROE: ventilators market, By mobility, 2018–2025 (USD MILLION) 161

TABLE 108     ROE: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 161

TABLE 109     ROE: ventilators market, By type, 2018–2025 (USD MILLION) 162

TABLE 110     ROE: ventilators market, By interface, 2018–2025 (USD MILLION) 162

TABLE 111     ROE: ventilators market, By Mode, 2018–2025 (USD MILLION) 162

TABLE 112     ROE: ventilators market, By end user, 2018–2025 (USD MILLION) 163

12.4          Asia Pacific. 163

TABLE 113     Asia Pacific: ventilators market, by country,

2018–2025 (USD MILLION) 164

TABLE 114     ASIA PACIFIC: ventilators market, By mobility,

2018–2025 (USD MILLION) 164

TABLE 115     ASIA PACIFIC: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 164

TABLE 116     ASIA PACIFIC: ventilators market, By type, 2018–2025 (USD MILLION) 165

TABLE 117     ASIA PACIFIC: ventilators market, By interface,

2018–2025 (USD MILLION) 165

TABLE 118     ASIA PACIFIC: ventilators market, By Mode, 2018–2025 (USD MILLION) 165

TABLE 119     ASIA PACIFIC: ventilators market, By end user,

2018–2025 (USD MILLION) 166

12.4.1             japan.. 166

12.4.1.1           Japan’s established healthcare system to support market growth during the forecast period  166

TABLE 120     Japan: Key Macroindicators for the Ventilators Market. 167

TABLE 121     JAPAN: ventilators market, By mobility, 2018–2025 (USD MILLION) 167

TABLE 122     JAPAN: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 168

TABLE 123     JAPAN: ventilators market, By type, 2018–2025 (USD MILLION) 168

TABLE 124     JAPAN: ventilators market, By interface, 2018–2025 (USD MILLION) 168

TABLE 125     JAPAN: ventilators market, By Mode, 2018–2025 (USD MILLION) 169

TABLE 126     JAPAN: ventilators market, By end user, 2018–2025 (USD MILLION) 169

12.4.2             china. 169

12.4.2.1           Growth in the patient population to stimulate market growth in China. 169

TABLE 127     China: Key Macroindicators for the Ventilators Market. 170

TABLE 128     CHINA: ventilators market, By mobility, 2018–2025 (USD MILLION) 170

TABLE 129     CHINA: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 171

TABLE 130     CHINA: ventilators market, By type, 2018–2025 (USD MILLION) 171

TABLE 131     CHINA: ventilators market, By interface, 2018–2025 (USD MILLION) 171

TABLE 132     CHINA: ventilators market, By Mode, 2018–2025 (USD MILLION) 172

TABLE 133     CHINA: ventilators market, By end user, 2018–2025 (USD MILLION) 172

12.4.3             india. 172

12.4.3.1           Increasing number of COVID-19 patient volume to drive the ventilators market in India  172

TABLE 134     India: Key Macroindicators for the Ventilators Market. 173

TABLE 135     INDIA: ventilators market, By mobility, 2018–2025 (USD MILLION) 173

TABLE 136     INDIA: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 174

TABLE 137     INDIA: ventilators market, By type, 2018–2025 (USD MILLION) 174

TABLE 138     INDIA: ventilators market, By interface, 2018–2025 (USD MILLION) 174

TABLE 139     INDIA: ventilators market, By Mode, 2018–2025 (USD MILLION) 175

TABLE 140     INDIA: ventilators market, By end user, 2018–2025 (USD MILLION) 175

12.4.4             australia. 175

12.4.4.1           High prevalence of chronic diseases to drive the demand for ventilators in Australia during the forecast period. 175

TABLE 141     australia: Key Macroindicators for the Ventilators Market. 176

TABLE 142     australia: ventilators market, By mobility,

2018–2025 (USD MILLION) 176

TABLE 143     australia: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 177

TABLE 144     australia: ventilators market, By type, 2018–2025 (USD MILLION) 177

TABLE 145     australia: ventilators market, By interface,

2018–2025 (USD MILLION) 177

TABLE 146     australia: ventilators market, By Mode, 2018–2025 (USD MILLION) 178

TABLE 147     australia: ventilators market, By end user,

2018–2025 (USD MILLION) 178

12.4.5             rest of Asia Pacific. 178

TABLE 148     ROAPAC: ventilators market, By mobility, 2018–2025 (USD MILLION) 179

TABLE 149     ROAPAC: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 179

TABLE 150     ROAPAC: ventilators market, By type, 2018–2025 (USD MILLION) 179

TABLE 151     ROAPAC: ventilators market, By interface, 2018–2025 (USD MILLION) 180

TABLE 152     ROAPAC: ventilators market, By Mode, 2018–2025 (USD MILLION) 180

TABLE 153     ROAPAC: ventilators market, By end user, 2018–2025 (USD MILLION) 180

12.5          LATIN AMERICA. 181

TABLE 154     Latin America: ventilators market, by country,

2018–2025 (USD MILLION) 181

TABLE 155     LATIN AMERICA: ventilators market, By mobility,

2018–2025 (USD MILLION) 181

TABLE 156     LATIN AMERICA: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 182

TABLE 157     LATIN AMERICA: ventilators market, By type,

2018–2025 (USD MILLION) 182

TABLE 158     LATIN AMERICA: ventilators market, By interface,

2018–2025 (USD MILLION) 182

TABLE 159     LATIN AMERICA: ventilators market, By Mode,

2018–2025 (USD MILLION) 183

TABLE 160     LATIN AMERICA: ventilators market, By end user,

2018–2025 (USD MILLION) 183

12.5.1             Brazil. 183

12.5.1.1           Healthcare infrastructure improvement to support market

growth in Brazil 183

TABLE 161     Brazil: Key Macroindicators for the Ventilators Market. 184

TABLE 162     BRAZIL: ventilators market, By mobility, 2018–2025 (USD MILLION) 184

TABLE 163     BRAZIL: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 185

TABLE 164     BRAZIL: ventilators market, By type, 2018–2025 (USD MILLION) 185

TABLE 165     BRAZIL: ventilators market, By interface, 2018–2025 (USD MILLION) 185

TABLE 166     BRAZIL: ventilators market, By Mode, 2018–2025 (USD MILLION) 186

TABLE 167     BRAZIL: ventilators market, By end user, 2018–2025 (USD MILLION) 186

12.5.2             mexico.. 186

12.5.2.1           Rising obesity rate to increase the incidence rate of respiratory diseases in Mexico. 186

TABLE 168     Mexico: Key Macroindicators for the Ventilators Market. 187

TABLE 169     MEXICO: ventilators market, By mobility, 2018–2025 (USD MILLION) 187

TABLE 170     MEXICO: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 188

TABLE 171     MEXICO: ventilators market, By type, 2018–2025 (USD MILLION) 188

TABLE 172     MEXICO: ventilators market, By interface, 2018–2025 (USD MILLION) 188

TABLE 173     MEXICO: ventilators market, By Mode, 2018–2025 (USD MILLION) 189

TABLE 174     MEXICO: ventilators market, By end user, 2018–2025 (USD MILLION) 189

12.5.3             rest of latin america. 189

TABLE 175     ROLATAM: ventilators market, By mobility, 2018–2025 (USD MILLION) 190

TABLE 176     ROLATAM: Intensive care ventilators market, By Type,

2018–2025 (USD MILLION) 190

TABLE 177     ROLATAM: ventilators market, By type, 2018–2025 (USD MILLION) 190

TABLE 178     ROLATAM: ventilators market, By interface,

 2018–2025 (USD MILLION) 191

TABLE 179     ROLATAM: ventilators market, By Mode, 2018–2025 (USD MILLION) 191

TABLE 180     ROLATAM: ventilators market, By end user,

2018–2025 (USD MILLION) 191

12.6          middle east & africa. 192

12.6.1             Increasing penetration of private health insurance is expected to drive the growth of this market further. 192

TABLE 181     Middle East & Africa: ventilators market, By mobility,

2018–2025 (USD MILLION) 192

TABLE 182     Middle East & Africa: Intensive care ventilators market, By Type, 2018–2025 (USD MILLION) 193

TABLE 183     Middle East & Africa: ventilators market, By type,

2018–2025 (USD MILLION) 193

TABLE 184     Middle East & Africa: ventilators market, By interface,

2018–2025 (USD MILLION) 193

TABLE 185     Middle East & Africa: ventilators market, By Mode,

2018–2025 (USD MILLION) 194

TABLE 186     Middle East & Africa: ventilators market, By end user,

2018–2025 (USD MILLION) 194

13.. COMPETITIVE LANDSCAPE. 195

13.1          OVERVIEW.. 195

FIGURE 42     key developments adopted by major players (JANUARY 2017–SEPTEMBER 2020) 195

13.2          MARKET EVALUATION FRAMEWORK. 196

FIGURE 43     MARKET EVALUATION FRAMEWORK: PARTNERSHIPS and COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES among key players in the ventilators market. 196

13.3          competitive SITUATIONS AND TRENDS. 196

13.3.1             Product Launches. 196

TABLE 187     Product Launches (january 2017– september 2020) 197

13.3.2             AcquisitioNs. 197

TABLE 188     Acquisitions (january 2017– september 2020) 197

13.3.3             PARTNERSHIPS and COLLABORATIONS. 198

TABLE 189     Partnerships and Collaborations (january 2017– september 2020) 198

13.3.4             Expansions. 199

TABLE 190     Expansions (january 2017– september 2020) 199

14.. company evaluation matrix and Company Profiles. 200

14.1          company evaluation matrix definition & methodology. 200

14.2          Competitive leadership mapping. 200

14.2.1             stars. 200

14.2.2             emerging leaders. 200

14.2.3             pervasive. 201

14.2.4             emerging companies. 201

FIGURE 44     ventilators market: Competitive Leadership Mapping (2019) 201

14.3          Market share analysis. 202

FIGURE 45     Philips healthcare: Market Leader in the ventilators market, 2019. 202

14.4          company profiles. 204

(Business Overview, Products Offered, Recent Developments, MnM View)*

14.4.1             Philips healthcare. 204

FIGURE 46     Philips healthcare: Company Snapshot (2019) 204

14.4.2             resMed, Inc. 207

FIGURE 47     resmed: Company Snapshot (2020) 207

14.4.3             medtronic plc. 210

FIGURE 48     medtronic plc: company snapshot (2020) 210

14.4.4             vyaire medical inc., 213

14.4.5             Getinge AB.. 215

FIGURE 49     Getinge AB: company snapshot (2019) 215

14.4.6             Drägerwerk AG & Co. KGaA. 218

FIGURE 50     Drägerwerk AG & Co. KGaA: company snapshot (2019) 218

14.4.7             smiths Group plc. 221

FIGURE 51     Smiths Group plc: company snapshot (2020) 221

14.4.8             hamilton medical. 223

14.4.9             Ge Healthcare. 225

FIGURE 52     GE healthcare: Company Snapshot (2019) 225

14.4.10          fisher & Paykel healthcare. 227

FIGURE 53     Fisher & Paykel healthcare: Company Snapshot (2019) 227

14.4.11          Air Liquide. 229

FIGURE 54     Air Liquide: Company Snapshot (2019) 229

14.4.12          Asahi Kasei corporation.. 232

FIGURE 55     Asahi Kasei corporation: Company Snapshot (2019) 232

14.4.13          Allied Healthcare Products. 234

FIGURE 56     Allied health Products: Company Snapshot (2020) 234

14.4.14          nihon kohden corporation.. 236

FIGURE 57     nihon kohden corporation: Company Snapshot (2019) 236

14.4.15          Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 238

14.4.16          axcent medical gmbh.. 238

14.4.17          metran co., ltd.. 239

14.4.18          magnamed.. 239

14.4.19          leistung.. 240

14.4.20          Avasarala Technologies Limited.. 240

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15.. Appendix. 241

15.1          insights of industry experts. 241

15.2          discussion guide. 242

15.3          Knowledge Store: MarketsandMarkets’ subscription portal. 247

15.4          Related Reports. 249

15.5          Author Details. 250



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127